Edition:
United Kingdom

Mithra Pharmaceuticals SA (MITRA.BR)

MITRA.BR on Brussels Stock Exchange

27.28EUR
19 Aug 2019
Change (% chg)

-- (--)
Prev Close
€27.28
Open
--
Day's High
--
Day's Low
--
Volume
--
Avg. Vol
33,815
52-wk High
€36.95
52-wk Low
€18.12

Revenue & Earnings Per Share

    Revenue* Earnings Per Share**
FY 2018 Dec '18 51.16 0.207
Jun '18 6.72 -1.023
FY 2017 Dec '17 26.57 -0.525
Jun '17 5.48 -0.655
 
*Note: Units in Millions ofEuro
**Note: Units in Euro

Consensus Estimates Analysis

  # of Estimates Mean High Low 1 Year Ago
SALES (in millions)
Year Ending Dec-19 4 98.05 148.00 35.20 112.83
Year Ending Dec-20 4 70.72 127.00 20.90 126.05
Earnings (per share)
Year Ending Dec-19 3 1.26 2.21 0.68 1.07
Year Ending Dec-20 2 0.70 0.72 0.69 3.06
Sales and Profit Figures in Euro (EUR);

Valuation Ratios

  Company industry sector
P/E Ratio (TTM) -- 29.73 33.85
P/E High - Last 5 Yrs. -- 47.56 54.29
P/E Low - Last 5 Yrs. -- 27.30 28.22
Beta 0.90 1.00 0.99
Price to Sales (TTM) 18.60 6.00 7.90
Price to Book (MRQ) 7.12 3.84 4.38
Price to Tangible Book (MRQ) 16.88 4.14 5.07
Price to Cash Flow (TTM) -- 21.62 23.70
% Owned Institutions -- 0.79 1.78

Dividends

  Company industry sector
Dividend Yield -- 1.83 1.67
Dividend Yield - 5 Year Avg -- 1.47 1.37
Dividend 5 Year Growth Rate -- 6.74 6.82
Payout Ratio(TTM) -- 50.64 46.67

Growth Rates

  Company industry sector
Sales (MRQ) vs Qtr. 1 Yr. Ago 92.58 13.42 14.65
Sales (TTM) vs TTM 1 Yr. Ago 80.63 6.45 8.45
Sales - 5 Yr. Growth Rate 26.77 8.32 9.43
EPS (MRQ) vs Qtr. 1 Yr. Ago 139.31 18.49 19.40
EPS (TTM) vs TTM 1 Yr. Ago 30.81 -- --
EPS - 5 Yr. Growth Rate -- 5.66 7.15
Capital Spending - 5 Yr. Growth Rate 77.50 7.02 8.01

Financial Strength

  Company industry sector
Quick Ratio (MRQ) 3.96 2.52 2.52
Current Ratio (MRQ) 4.26 3.55 3.52
LT Debt to Equity (MRQ) 103.38 11.64 12.61
Total Debt to Equity (MRQ) 116.80 16.17 17.64
Interest Coverage (TTM) -1.03 7.61 14.93

Profitability Ratios

  Company industry sector
Gross Margin (TTM) 93.87 51.41 50.25
Gross Margin - 5 Yr. Avg. 65.30 50.53 51.36
EBITD Margin (TTM) 29.44 -- --
EBITD - 5 Yr. Avg -25.48 17.64 16.42
Operating Margin (TTM) 24.51 -2.19 -6.97
Operating Margin - 5 Yr. Avg. -42.90 13.94 11.87
Pre-Tax Margin (TTM) -64.78 -2.50 -7.30
Pre-Tax Margin - 5 Yr. Avg. -97.13 18.73 15.72
Net Profit Margin (TTM) -47.70 -6.21 -11.11
Net Profit Margin - 5 Yr. Avg. -74.96 14.06 11.11
Effective Tax Rate (TTM) -- 20.27 20.61
Effective Tax Rate - 5 Yr. Avg. -- 22.92 24.51

Efficiency

  Company industry sector
Revenue/Employee (TTM) 448,651 1,012,949,194 870,638,159
Net Income/Employee (TTM) -214,000 118,477,208 101,855,832
Receivable Turnover (TTM) 2.01 5.61 5.88
Inventory Turnover (TTM) 0.47 2.59 3.66
Asset Turnover (TTM) 0.19 0.88 0.85

Management Effectiveness

  Company industry sector
Return on Assets (TTM) -9.20 10.57 10.25
Return on Assets - 5 Yr. Avg. -13.84 11.70 11.17
Return on Investment (TTM) -10.78 13.04 12.69
Return on Investment - 5 Yr. Avg. -16.80 14.80 14.15
Return on Equity (TTM) -23.22 14.12 17.13
Return on Equity - 5 Yr. Avg. -29.22 15.92 15.53
  1 Year 3 Year 5 Year
Sales % 80.63 41.48 26.77
EPS (TTM) % 35.72 -- --
Dividend % -- -- --
Note: Units in Millions of US Dollars

Performance for Mithra Pharmaceuticals SA

Period %
Actual
% vs.
S&P 500
Rank In
Industry
Industry
Rank
4 Week 11.08 5.47 99 47
13 Week 9.80 9.56 99 34
26 Week 5.83 -0.94 99 15
52 Week -19.66 -16.67 95 66
YTD 43.40 24.50 99 20
Note:: Rank is a percentile that ranges from 0 to 99, with 99 = best.

Institutional Holders

% Shares Owned: 18.80%
# of Holders: 37
Total Shares Held: 7,086,486
3 Mo. Net Change: 63,685
# New Positions: 1
# Closed Positions: 0
# Increased Positions: 12
# Reduced Positions: 1
# Net Buyers: 11
NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.